Pre-Implantation Genetic Testing (PGD/PGS)

Screen embryos for genetic conditions and chromosomal abnormalities before transfer, improving IVF success and reducing the risk of genetic disease.

What is PGD?

Pre-Implantation Genetic Diagnosis (PGD) and Pre-Implantation Genetic Screening (PGS/PGT-A) are techniques used during IVF to test embryos for genetic conditions or chromosomal abnormalities before they are transferred to the uterus. This allows us to select embryos with the highest potential for a healthy pregnancy.

Who Needs Genetic Testing?

How Does PGD/PGS Work?

1. Standard IVF Cycle

The process begins with a normal IVF stimulation cycle, egg retrieval, and fertilisation (usually with ICSI to avoid contamination with foreign DNA).

2. Embryo Biopsy

On day 5-6, when embryos reach the blastocyst stage, our embryologist removes a small number of cells (5-10) from the trophectoderm — the outer layer that will become the placenta. This does not harm the inner cell mass that becomes the baby.

3. Genetic Analysis

The biopsied cells are sent to a specialised genetics laboratory for analysis. Results are typically available within 1-2 weeks. During this time, embryos are vitrified (frozen) to await results.

4. Embryo Selection & Transfer

Once results are available, only embryos that are genetically normal (for the tested condition) and chromosomally balanced are selected for frozen embryo transfer.

Carrier Screening

Before embarking on PGD, both partners undergo carrier screening — blood tests that identify whether you carry genes for specific inherited conditions. This information determines which conditions to test embryos for and ensures that PGD is technically feasible for your specific genetic situation.

Common conditions screened in South Africa include:

Related Resources

Genetic Testing FAQ

Does PGD guarantee a healthy baby?

PGD significantly reduces the risk of the specific conditions tested for, but cannot guarantee a completely healthy pregnancy. It tests for specific genetic conditions, not all possible health issues.

Will the biopsy harm my embryo?

Trophectoderm biopsy at the blastocyst stage is well-established and safe. Studies show no increased risk of birth defects or developmental issues in children born after PGD.

Can PGD be used for sex selection?

In South Africa, sex selection for non-medical reasons is not permitted. PGD may determine embryo sex when testing for sex-linked genetic conditions.

How much does PGD add to the cost of IVF?

PGD/PGS adds additional cost to the standard IVF cycle for the biopsy procedure and genetic laboratory analysis. We provide detailed cost breakdowns during consultation.

What if no embryos pass the genetic test?

This is possible, particularly with small numbers of embryos or complex genetic conditions. If no embryos are suitable for transfer, we discuss options including a further IVF cycle.

Take The Next Step

Ready for your little miracle?

Our compassionate team is ready to guide you every step of the way. Book a consultation and take the first step towards growing your family.

Book a consultation →
Not ready yet? Join our Priority Circle for early access to slots & monthly fertility insights.

Join Our Priority Circle

Get early access to new treatment slots, monthly fertility insights from our specialists, and priority booking when you’re ready to start your journey.

No spam, no commitment. Unsubscribe anytime. Your details are processed under POPIA and our Privacy Policy — used only to send you insights and priority slots.